AMAG Pharmaceuticals Inc. (AMAG)

12.03
0.13 1.10
NASDAQ : Health Technology
Prev Close 12.16
Open 12.18
Day Low/High 11.80 / 12.27
52 Wk Low/High 14.35 / 26.10
Volume 168.52K
Avg Volume 736.50K
Exchange NASDAQ
Shares Outstanding 34.71M
Market Cap 441.20M
EPS -4.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week Of November 15th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of November 15th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the November 15th expiration.

First Week Of August 16th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of August 16th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the August 16th expiration.

AMAG Pharmaceuticals Becomes Oversold (AMAG)

AMAG Pharmaceuticals Becomes Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Becomes Oversold (AMAG)

AMAG Pharmaceuticals Becomes Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $21.15, changing hands as low as $16.91 per share.

AMAG Crosses Above Average Analyst Target

AMAG Crosses Above Average Analyst Target

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $22.88, changing hands for $23.68/share.

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

AMAG Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMAG

In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $20.19, changing hands as low as $20.05 per share.

AMAG Crosses Above Average Analyst Target

AMAG Crosses Above Average Analyst Target

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $22.44, changing hands for $22.50/share.

First Week Of AMAG September 21st Options Trading

First Week Of AMAG September 21st Options Trading

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the September 21st expiration.

Relative Strength Alert For AMAG Pharmaceuticals

Relative Strength Alert For AMAG Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of February 2019 Options Trading For AMAG Pharmaceuticals (AMAG)

First Week Of February 2019 Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the February 2019 expiration.

First Week Of AMAG July 20th Options Trading

First Week Of AMAG July 20th Options Trading

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the July 20th expiration.

AMAG Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $20.55, changing hands for $20.70/share.

First Week Of June 15th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the June 15th expiration.

AMAG Will Make You Think Biotech Again

AMAG Will Make You Think Biotech Again

When this stock hit my breakout scan, I paid it a bit of extra attention.

AMAG Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of AMAG Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $20.80, changing hands for $21.00/share.

First Week Of AMAG November 16th Options Trading

First Week Of AMAG November 16th Options Trading

Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the November 16th expiration.

First Week of April 20th Options Trading For AMAG Pharmaceuticals (AMAG)

First Week of April 20th Options Trading For AMAG Pharmaceuticals (AMAG)

Investors in AMAG Pharmaceuticals, Inc. saw new options become available this week, for the April 20th expiration.

AMAG Pharmaceuticals Announces FDA Approval Of Makena® (hydroxyprogesterone Caproate Injection) Subcutaneous Auto-Injector To Reduce The Risk Of Preterm Birth In Certain At-Risk Women

AMAG Pharmaceuticals Announces FDA Approval Of Makena® (hydroxyprogesterone Caproate Injection) Subcutaneous Auto-Injector To Reduce The Risk Of Preterm Birth In Certain At-Risk Women

Marks Second FDA Approval for AMAG this Month; Company to File NDA for Bremelanotide, A Novel Women's Health Product, Later this Quarter

AMAG Pharmaceuticals Announces FDA Approval Of Supplemental New Drug Application (sNDA) For Feraheme® (ferumoxytol Injection)

AMAG Pharmaceuticals Announces FDA Approval Of Supplemental New Drug Application (sNDA) For Feraheme® (ferumoxytol Injection)

Feraheme is Now a Treatment Option for All Eligible Adult Patients with Iron Deficiency Anemia

Noteworthy Monday Option Activity: AMAG, ACIA, HCA

Noteworthy Monday Option Activity: AMAG, ACIA, HCA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in AMAG Pharmaceuticals, Inc. , where a total volume of 4,588 contracts has been traded thus far today, a contract volume which is representative of approximately 458,800 underlying shares (given that every 1 contract represents 100 underlying shares).

New Patent Issued To AMAG Pharmaceuticals Entitled "Methods Of Reducing Risk Of Preterm Birth"

New Patent Issued To AMAG Pharmaceuticals Entitled "Methods Of Reducing Risk Of Preterm Birth"

Patent designed to protect the subcutaneous administration of Makena(R) (hydroxyprogesterone caproate injection)

TheStreet Quant Rating: D+ (Sell)